Diarrhea and associated factors among under-5 children in Ethiopia: A secondary data analysis

Getahun Fetensa1, Ginenus Fekadu2, Firew Tekle3

  • 1School of Nursing and Midwifery, Institute of Health Sciences, Wollega University, Nekemte, Ethiopia.

SAGE Open Medicine
|August 22, 2020
PubMed

Insights

Diarrhea remains a significant threat to children under five in Ethiopia. Key predictors include delayed breastfeeding initiation and lack of prenatal care, highlighting the need for maternal education.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Diarrhea is a leading cause of preventable death in children under five globally.
  • While incidence is decreasing, the impact of diarrhea is rising, especially in developing nations.
  • Ethiopia faces a significant burden of childhood diarrhea.

Purpose of the Study:

  • To assess the prevalence of diarrhea among children under five in Ethiopia.
  • To identify factors associated with childhood diarrhea using nationally representative data.

Main Methods:

  • Utilized data from the 2016 Ethiopian National Survey.
  • Employed logistic regression to identify independent predictors of childhood diarrhea.
  • Considered variables with p < 0.05 as significant predictors.

Main Results:

  • 10.2% of 10,641 children under five experienced diarrhea.
  • Independent predictors included delayed breastfeeding initiation (AOR=1.553) and lack of prenatal care (AOR=2.142).
  • Receiving no treatment for fever/cough (AOR=0.170) and permanent residence (AOR=0.583) were also significant.

Conclusions:

  • Diarrhea poses a substantial health challenge for Ethiopian children under five.
  • Maternal and child health education focusing on identified predictive factors is crucial for intervention.
  • Targeted educational programs can help mitigate the impact of childhood diarrhea.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
338
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
480
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
507
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
494
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
616
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.2K